Emerald Bioscience Probability of Future OTC Stock Price Finishing Over 0.5525

Emerald Bioscience's future price is the expected price of Emerald Bioscience instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Emerald Bioscience performance during a given time horizon utilizing its historical volatility. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
  
Please specify Emerald Bioscience's target price for which you would like Emerald Bioscience odds to be computed.

Emerald Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Emerald Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Emerald Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Emerald Bioscience is not yet fully synchronised with the market data
Emerald Bioscience has some characteristics of a very speculative penny stock
Emerald Bioscience has a very high chance of going through financial distress in the upcoming years
The company currently holds 1.36 M in liabilities. Emerald Bioscience has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emerald Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Emerald Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emerald Bioscience sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emerald to invest in growth at high rates of return. When we think about Emerald Bioscience's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 399.91 K. Net Loss for the year was (19.19 M) with profit before overhead, payroll, taxes, and interest of 166.22 K.
Emerald Bioscience currently holds about 1.85 M in cash with (3.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 60.0% of the company outstanding shares are owned by corporate insiders

Emerald Bioscience Technical Analysis

Emerald Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. Emerald OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Emerald Bioscience. In general, you should focus on analyzing Emerald OTC Stock price patterns and their correlations with different microeconomic environments and drivers.

Emerald Bioscience Predictive Forecast Models

Emerald Bioscience's time-series forecasting models is one of many Emerald Bioscience's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Emerald Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.

Things to note about Emerald Bioscience

Checking the ongoing alerts about Emerald Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Emerald Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Emerald Bioscience is not yet fully synchronised with the market data
Emerald Bioscience has some characteristics of a very speculative penny stock
Emerald Bioscience has a very high chance of going through financial distress in the upcoming years
The company currently holds 1.36 M in liabilities. Emerald Bioscience has a current ratio of 0.12, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Emerald Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Emerald Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Emerald Bioscience sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Emerald to invest in growth at high rates of return. When we think about Emerald Bioscience's use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 399.91 K. Net Loss for the year was (19.19 M) with profit before overhead, payroll, taxes, and interest of 166.22 K.
Emerald Bioscience currently holds about 1.85 M in cash with (3.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Roughly 60.0% of the company outstanding shares are owned by corporate insiders
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Consideration for investing in Emerald OTC Stock

If you are still planning to invest in Emerald Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emerald Bioscience's history and understand the potential risks before investing.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios